From the Editor-in-Chief

Patients in this age group have particular needs, and cancer centers are beginning to tailor programs for them.

by William G. Nelson, MD, PhD

Forward Look

Despite efforts by policymakers, a gender gap persists in clinical trial participation.

by Lindsey Konkel

Forward Look

Several targeted drugs were approved in 2020 to treat the most common type of lung cancer.

by Ashley P. Taylor

Forward Look

Treatments capable of crossing the blood-brain barrier provide new options for patients whose cancer has spread to the brain.

by Bradley Jones

Forward Look

Some rectal cancer patients may safely avoid life-altering surgery.

by Kristine Conner

Forward Look

Many older adults continue to be screened beyond the recommended age.

by Carisa Brewster

Healthy Habits

Aspirin can be taken daily to reduce the risk of colorectal cancer, but it's not recommended for everyone.

by Bradley Jones

Forward Look

A new way to evaluate patients with prostate cancer.

by Christina Bennett

New drugs and drug combinations are helping more patients live longer with advanced kidney cancer. But questions remain about how best to choose among them.

by Kendall K. Morgan

People with cancer that has spread to only a few locations—called oligometastatic cancer—may benefit from aggressive local treatment.

by Kate Yandell